A fusion of two existing drugs alleviates autism-like features in a mouse model of the condition, according to a new study1.
The fusion drug, called NitroSynapsin, boosts social interest and alleviates some repetitive behaviors in mice missing one copy of the autism candidate gene MEF2C.
The drug ap…